|
1
|
Cloughesy TF, Cavenee WK and Mischel PS:
Glioblastoma: From molecular pathology to targeted treatment. Annu
Rev Pathol. 9:1–25. 2014. View Article : Google Scholar
|
|
2
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Annibali D, Whitfield JR, Favuzzi E,
Jauset T, Serrano E, Cuartas I, Redondo-Campos S, Folch G,
Gonzàlez-Juncà A, Sodir NM, et al: Myc inhibition is effective
against glioma and reveals a role for Myc in proficient mitosis.
Nat Commun. 5:46322014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ahmed R, Oborski MJ, Hwang M, Lieberman FS
and Mountz JM: Malignant gliomas: Current perspectives in
diagnosis, treatment, and early response assessment using advanced
quantitative imaging methods. Cancer Manag Res. 6:149–170.
2014.PubMed/NCBI
|
|
5
|
Martin C and Zhang Y: Mechanisms of
epigenetic inheritance. Curr Opin Cell Biol. 19:266–272. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou VW, Goren A and Bernstein BE:
Charting histone modifications and the functional organization of
mammalian genomes. Nat Rev Genet. 12:7–18. 2011. View Article : Google Scholar
|
|
7
|
Van Aller GS, Reynoird N, Barbash O,
Huddleston M, Liu S, Zmoos AF, McDevitt P, Sinnamon R, Le B, Mas G,
et al: Smyd3 regulates cancer cell phenotypes and catalyzes histone
H4 lysine 5 methylation. Epigenetics. 7:340–343. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cock-Rada AM, Medjkane S, Janski N, Yousfi
N, Perichon M, Chaussepied M, Chluba J, Langsley G and Weitzman JB:
SMYD3 promotes cancer invasion by epigenetic upregulation of the
metalloproteinase MMP-9. Cancer Res. 72:810–820. 2012. View Article : Google Scholar :
|
|
9
|
He C, Xu J, Zhang J, Xie D, Ye H, Xiao Z,
Cai M, Xu K, Zeng Y, Li H, et al: High expression of trimethylated
histone H3 lysine 4 is associated with poor prognosis in
hepatocellular carcinoma. Hum Pathol. 43:1425–1435. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu L, Kimball S, Liu H, Holowatyj A and
Yang ZQ: Genetic alterations of histone lysine methyltransferases
and their significance in breast cancer. Oncotarget. 6:2466–2482.
2015. View Article : Google Scholar :
|
|
11
|
Liu Y, Deng J, Luo X, Pan Y, Zhang L,
Zhang R and Liang H: Overexpression of SMYD3 was associated with
increased STAT3 activation in gastric cancer. Med Oncol.
32:4042015. View Article : Google Scholar
|
|
12
|
Luo XG, Xi T, Guo S, Liu ZP, Wang N, Jiang
Y and Zhang TC: Effects of SMYD3 overexpression on transformation,
serum dependence, and apoptosis sensitivity in NIH3T3 cells. IUBMB
Life. 61:679–684. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu LX, Li ZH, Tao YF, Li RH, Fang F, Zhao
H, Li G, Li YH, Wang J, Feng X, et al: Histone acetyltransferase
inhibitor II induces apoptosis in glioma cell lines via the p53
signaling pathway. J Exp Clin Cancer Res. 33:1082014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cohen AL and Colman H: Glioma biology and
molecular markers. Cancer Treat Res. 163:15–30. 2015. View Article : Google Scholar
|
|
15
|
Chuikov S, Kurash JK, Wilson JR, Xiao B,
Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, et
al: Regulation of p53 activity through lysine methylation. Nature.
432:353–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang J, Perez-Burgos L, Placek BJ,
Sengupta R, Richter M, Dorsey JA, Kubicek S, Opravil S, Jenuwein T
and Berger SL: repression of p53 activity by Smyd2-mediated
methylation. Nature. 444:629–632. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang q, Wang Y, Zhang Y, Zhang Y and Xiao
W: The role of uPAR in epithelial-mesenchymal transition in small
airway epithelium of patients with chronic obstructive pulmonary
disease. Respir Res. 14:672013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang
P, He X, Wang Q, Huang Y, Jen KY, et al: CUL4A induces
epithelial-mesenchymal transition and promotes cancer metastasis by
regulating ZEB1 expression. Cancer Res. 74:520–531. 2014.
View Article : Google Scholar :
|
|
20
|
Zheng H, Ying H, Yan H, Kimmelman AC,
Hiller DJ, Chen AJ, Perry SR, Tonon G, Chu GC, Ding Z, et al: p53
and Pten control neural and glioma stem/progenitor cell renewal and
differentiation. Nature. 455:1129–1133. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang SZ, Luo XG, Shen J, Zou JN, Lu YH and
Xi T: Knockdown of SMYD3 by RNA interference inhibits cervical
carcinoma cell growth and invasion in vitro. BMB Rep. 41:294–299.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sponziello M, Durante C, Boichard A, Dima
M, Puppin C, Verrienti A, Tamburrano G, Di Rocco G, Redler A,
Lacroix L, et al: Epigenetic-related gene expression profile in
medullary thyroid cancer revealed the overexpression of the histone
methyltransferases EZH2 and SMYD3 in aggressive tumours. Mol Cell
Endocrinol. 392:8–13. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Liu H, Luo X, Deng J, Pan Y and
Liang H: Overexpression of SMYD3 and matrix metalloproteinase-9 are
associated with poor prognosis of patients with gastric cancer.
Tumour Biol. Jan 28–2015.Epub ahead of print. View Article : Google Scholar
|
|
24
|
Suzuki S, Nozawa Y, Tsukamoto S, Kaneko T,
Imai H and Minami N: Histone methyltransferase Smyd3 regulates
early embryonic lineage commitment in mice. Reproduction.
150:21–30. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hamamoto R, Silva FP, Tsuge M, Nishidate
T, Katagiri T, Nakamura Y and Furukawa Y: Enhanced SMYD3 expression
is essential for the growth of breast cancer cells. Cancer Sci.
97:113–118. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ren TN, Wang JS, He YM, Xu CL, Wang SZ and
Xi T: Effects of SMYD3 over-expression on cell cycle acceleration
and cell proliferation in MDA-MB-231 human breast cancer cells. Med
Oncol. 28(Suppl 1): S91–S98. 2011. View Article : Google Scholar
|
|
27
|
Liu Y, Luo X, Deng J, Pan Y, Zhang L and
Liang H: SMYD3 overexpression was a risk factor in the biological
behavior and prognosis of gastric carcinoma. Tumour Biol.
36:2685–2694. 2015. View Article : Google Scholar
|
|
28
|
Xu Y, Wang Y, Ma G, Wang Q and Wei G:
CUL4A is overexpressed in human pituitary adenomas and regulates
pituitary tumor cell proliferation. J Neurooncol. 116:625–632.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Ma G, Wang Q, Wen M, Xu Y, He X,
Zhang P, Wang Y, Yang T, Zhan P, et al: Involvement of CUL4A in
regulation of multidrug resistance to P-gp substrate drugs in
breast cancer cells. Molecules. 19:159–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
